Daptomycin Nge Cas 103060-53-3 99% Ubunyulu
I-Datomicin sisibulali-zintsholongwane esitsha esakhiweyo se-cyclic lipopeptide ekhutshwa kumhluzi wokubilisa we-Streptomyces. Ukongeza ekusebenzeni kwiibhaktheriya ezininzi zegram-positive, kubaluleke kakhulu ukuba inomsebenzi oqinileyo kwi-vitro ngokuchasene neentlobo ezizimeleyo ezibonise ukuxhathisa i-methicillin, i-vancomycin kunye ne-linezolidine, olu phawu lubaluleke kakhulu ukubaluleka kwekliniki kwizigulana ezosulelekileyo.
| Igama lemveliso: | Daptomycin | Inombolo yeqela. | JL20220811 |
| Cas | 103060-53-3 | MF Umhla | Agasti 11, 2022 |
| Ukupakisha | 1KG/BAG | Umhla wohlalutyo | Agasti 11, 2022 |
| Ubungakanani | 100KGS | Umhla WOKUPHELELWA | Agasti 10, 2024 |
| ITEM | SI-TANDARD | IZIPHUMO | |
| Imbonakalo | Umthubi okhanyayo ukuya kumgubo omthubi | Vumelana | |
| Ivumba | Ayinavumba | Vumelana | |
| Isivavanyi | ≥95.0% | 97.9% | |
| I-optical ethileukujikeleza | +15.5+20.5 | +16,8 | |
| Ukucaca kwesisombululo | Icacisiwe | Icacisiwe | |
| PH | 3.0-4.5 | 3.2 | |
| Intsalela ekutshisweni | ≤0.2% | 0.1% | |
| Amanzi | ≤5.0% | 2.4% | |
| ILactone hydrolyzate | ≤0.80% | 0.08% | |
| β-isomere | ≤1.5% | 0.1% | |
| RS-5/6 | ≤0.80% | 0.06% | |
| RS-7 | ≤0.80% | Ayifunyaniswanga | |
| RS-7a/7b | ≤0.20% | 0.07% | |
| I-Anhydrodaptomycin | ≤2.0% | 0.8% | |
| Omnye umntu | ≤0.15% | Ayifunyaniswanga | |
| Ukungcola okupheleleyo | ≤5.0% | 1.1% | |
| Ethyl utywala | ≤0.5% | 0.0% | |
| Acetic acid | ≤0.5% | Ayifunyaniswanga | |
| I-endotoxin yebhaktheriya(EU/mg) | ≤0.28 | <0.28 | |
| Iibhaktheriya zeAerobic(cfu/g) | ≤1000 | <10 | |
| Umngundo & negwele(cfu/g) | ≤100 | <10 | |
| E.coil | Ayifunyaniswanga | Ayifunyaniswanga | |
| Ukuqukumbela | Ufanelekile | ||
Unyango oluphakathi kunyango losulelo lwesikhumba kunye nesakhiwo solusu olubangelwa ziintlobo ezithile zegram-positive kunye nobuthathaka.
Ibhegi ye-1kgs okanye imfuno yabathengi. Yigcine kude nokukhanya kubushushu obungaphantsi kwe 25℃.
I-Daptomycin Nge-Cas 103060-53-3












